As of 2025-01-25, the Relative Valuation of Coherus BioSciences Inc (CHRS) is (0.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.24 USD, the upside of Coherus BioSciences Inc based on Relative Valuation is -107.0%.
The range of the Relative Valuation is (0.07) - (0.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.7x - 22.0x | 17.4x |
| Forward P/E multiples | 18.7x - 35.4x | 27.0x |
| Fair Price | (0.07) - (0.09) | (0.09) |
| Upside | -105.9% - -106.9% | -107.0% |
| Date | P/E |
| 2025-01-24 | -317.47 |
| 2025-01-23 | -327.71 |
| 2025-01-22 | -335.39 |
| 2025-01-21 | -337.95 |
| 2025-01-17 | -355.87 |
| 2025-01-16 | -363.55 |
| 2025-01-15 | -373.79 |
| 2025-01-14 | -368.67 |
| 2025-01-13 | -376.35 |
| 2025-01-10 | -376.35 |
| 2025-01-08 | -386.59 |
| 2025-01-07 | -401.95 |
| 2025-01-06 | -414.76 |
| 2025-01-03 | -425.00 |
| 2025-01-02 | -358.43 |
| 2024-12-31 | -353.31 |
| 2024-12-30 | -384.03 |
| 2024-12-27 | -381.47 |
| 2024-12-26 | -381.47 |
| 2024-12-24 | -376.35 |
| 2024-12-23 | -366.11 |
| 2024-12-20 | -389.15 |
| 2024-12-19 | -378.91 |
| 2024-12-18 | -401.95 |
| 2024-12-17 | -437.80 |
| 2024-12-16 | -435.24 |
| 2024-12-13 | -412.20 |
| 2024-12-12 | -384.03 |
| 2024-12-11 | -422.44 |
| 2024-12-10 | -412.20 |
| 2024-12-09 | -435.24 |
| 2024-12-06 | -435.24 |
| 2024-12-05 | -386.59 |
| 2024-12-04 | -437.80 |
| 2024-12-03 | -437.80 |
| 2024-12-02 | -350.75 |
| 2024-11-29 | -312.35 |
| 2024-11-27 | -322.59 |
| 2024-11-26 | -327.71 |
| 2024-11-25 | -309.79 |
| 2024-11-22 | -279.06 |
| 2024-11-21 | -281.62 |
| 2024-11-20 | -281.62 |
| 2024-11-19 | -210.32 |
| 2024-11-18 | -200.03 |
| 2024-11-15 | -190.48 |
| 2024-11-14 | -197.80 |
| 2024-11-13 | -199.36 |
| 2024-11-12 | -210.83 |
| 2024-11-11 | -199.39 |